{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T11:24:14Z","timestamp":1777634654218,"version":"3.51.4"},"reference-count":20,"publisher":"CSIRO Publishing","issue":"4","license":[{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"vor","delay-in-days":4019,"URL":"https:\/\/doi.org\/10.1071\/journalslicense"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,9,9]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hepatitis E virus (HEV) infection has been found to cause chronic hepatitis in HIV-infected patients. In Australia, where HEV is nonendemic, background seroprevalence is reportedly low but has not been evaluated in the HIV-infected population. The study aimed to assess the seroprevalence of HEV in a cohort of HIV-infected patients with normal liver function and in another group with biochemical hepatitis. Methods: Patients were selected from the Victorian HIV Blood and Tissue Storage Bank and stored plasma was tested. Positive HEV antibody specimens were examined for HEV RNA by polymerase chain reaction. Results: A total of 191 HIV patients were tested for HEV by serology. Eight of 100 (8%) HIV-infected patients with normal liver function and 4 of 91 (4.4%) of those with biochemical hepatitis had HEV antibodies. All four patients with abnormal liver function and positive HEV serology were coinfected with hepatitis C and were significantly more likely to have higher median alanine aminotransferase levels (382 vs 139 U L\u20131, P = 0.01). HEV-positive patients with normal liver function were more likely to be born outside Australia (P = 0.004). Two of four patients with biochemical hepatitis who were seropositive for HEV had detectable HEV RNA. Conclusions: The seroprevalence of HEV in this Australian HIV-infected cohort is higher than the estimated background prevalence in the HIV-negative population. In patients coinfected with hepatitis C, the degree of alanine aminotransferase elevation was significantly worse. HEV may contribute to the development of abnormal liver function.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1071\/sh13198","type":"journal-article","created":{"date-parts":[[2014,8,27]],"date-time":"2014-08-27T19:59:57Z","timestamp":1409169597000},"page":"375-378","source":"Crossref","is-referenced-by-count":10,"title":["Hepatitis E in Australian HIV-infected patients: an under-recognised pathogen?"],"prefix":"10.1071","volume":"11","author":[{"given":"Michelle K.","family":"Yong","sequence":"first","affiliation":[{"name":"ADepartment of Infectious Diseases, The Alfred Hospital, Commercial Road, Melbourne, Vic. 3004, Australia."},{"name":"CDepartment of Medicine, Monash University, Melbourne, Vic. 3004, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma K.","family":"Paige","sequence":"additional","affiliation":[{"name":"ADepartment of Infectious Diseases, The Alfred Hospital, Commercial Road, Melbourne, Vic. 3004, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Anderson","sequence":"additional","affiliation":[{"name":"BBurnet Institute, Commercial Road, Melbourne, Vic. 3004, Australia."},{"name":"DDepartment of Immunology, Monash University, Melbourne, Vic. 3004, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer F.","family":"Hoy","sequence":"additional","affiliation":[{"name":"ADepartment of Infectious Diseases, The Alfred Hospital, Commercial Road, Melbourne, Vic. 3004, Australia."},{"name":"CDepartment of Medicine, Monash University, Melbourne, Vic. 3004, Australia."},{"name":"ECorresponding author. Email: Jennifer.Hoy@monash.edu"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"67","published-online":{"date-parts":[[2014,8,28]]},"reference":[{"key":"2025102617095548200_R1","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1002\/hep.25505","article-title":"The global burden of hepatitis E virus genotypes 1 and 2 in 2005.","volume":"55","author":"Rein","year":"2012","journal-title":"Hepatology"},{"key":"2025102617095548200_R2","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/jvh.12156","article-title":"Chronic hepatitis E: a review of the literature.","volume":"21","author":"Fujiwara","year":"2014","journal-title":"J Viral Hepat"},{"key":"2025102617095548200_R3","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1056\/NEJMc0903778","article-title":"Persistent carriage of hepatitis E virus in patients with HIV infection.","volume":"361","author":"Dalton","year":"2009","journal-title":"N Engl J Med"},{"key":"2025102617095548200_R4","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1056\/NEJMoa0706992","article-title":"Hepatitis E virus and chronic hepatitis in organ-transplant recipients.","volume":"358","author":"Kamar","year":"2008","journal-title":"N Engl J Med"},{"key":"2025102617095548200_R5","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1002\/jmv.1890450316","article-title":"Seroepidemiology of hepatitis E in selected Australian populations.","volume":"45","author":"Moaven","year":"1995","journal-title":"J Med Virol"},{"key":"2025102617095548200_R6","doi-asserted-by":"publisher","first-page":"482","DOI":"10.3201\/eid1103.040706","article-title":"Hepatitis E infections, Victoria, Australia.","volume":"11","author":"Cowie","year":"2005","journal-title":"Emerg Infect Dis"},{"key":"2025102617095548200_R7","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1053\/j.gastro.2011.07.051","article-title":"Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury.","volume":"141","author":"Davern","year":"2011","journal-title":"Gastroenterology"},{"key":"2025102617095548200_R8","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1128\/CVI.00186-07","article-title":"Double-antigen enzyme-linked immunosorbent assay for detection of hepatitis E virus-specific antibodies in human or swine sera.","volume":"15","author":"Hu","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"2025102617095548200_R9"},{"key":"2025102617095548200_R10","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1111\/j.1365-2893.2009.01219.x","article-title":"Hepatitis E in HIV-positive patients in a low-endemic country.","volume":"17","author":"Pischke","year":"2010","journal-title":"J Viral Hepat"},{"key":"2025102617095548200_R11","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1468-1293.2011.00942.x","article-title":"Hepatitis E virus coinfection in patients with HIV infection.","volume":"13","author":"Keane","year":"2012","journal-title":"HIV Med"},{"key":"2025102617095548200_R12","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1046\/j.1365-2893.1997.00050.x","article-title":"Antibody to hepatitis E virus in HIV-infected individuals and AIDS patients.","volume":"4","author":"Balayan","year":"1997","journal-title":"J Viral Hepat"},{"key":"2025102617095548200_R13","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1111\/j.1469-0691.2008.02102.x","article-title":"Hepatitis E virus as a newly identified cause of acute viral hepatitis during human immunodeficiency virus infection.","volume":"14","author":"Colson","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"2025102617095548200_R14","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jinf.2011.11.027","article-title":"Chronic hepatitis E as a cause for cryptogenic cirrhosis in HIV.","volume":"66","author":"Jagjit Singh","year":"2011","journal-title":"J Infect"},{"key":"2025102617095548200_R15","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.jcv.2009.06.002","article-title":"Hepatitis E in an HIV-infected patient.","volume":"45","author":"Colson","year":"2009","journal-title":"J Clin Virol"},{"key":"2025102617095548200_R16","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1111\/j.1365-2893.2009.01138.x","article-title":"Lack of hepatitis E virus infection in HIV patients with advanced immunodeficiency or idiopathic liver enzyme elevations.","volume":"16","author":"Madej\u00f3n","year":"2009","journal-title":"J Viral Hepat"},{"key":"2025102617095548200_R17","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/S1473-3099(08)70255-X","article-title":"Hepatitis E: an emerging infection in developed countries.","volume":"8","author":"Dalton","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"2025102617095548200_R18","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1086\/652716","article-title":"Should HIV-infected patients with unexplained chronic liver enzyme elevations be tested for hepatitis E virus?","volume":"50","author":"Kuniholm","year":"2010","journal-title":"Clin Infect Dis"},{"key":"2025102617095548200_R19","doi-asserted-by":"publisher","first-page":"e65","DOI":"10.1097\/QAI.0b013e318251b01f","article-title":"Hepatitis E virus as a causative agent of unexplained liver enzyme elevations in HIV-infected patients.","volume":"60","author":"van Welzen","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2025102617095548200_R20","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1093\/infdis\/jis688","article-title":"Test performance characteristics of Anti-HEV IgG assays strongly influence hepatitis E seroprevalence estimates.","volume":"207","author":"Wenzel","year":"2013","journal-title":"J Infect Dis"}],"container-title":["Sexual Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/connectsci.au\/sh\/article-pdf\/11\/4\/375\/1254898\/sh13198.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/connectsci.au\/sh\/article-pdf\/11\/4\/375\/1254898\/sh13198.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:10:04Z","timestamp":1761513004000},"score":1,"resource":{"primary":{"URL":"https:\/\/connectsci.au\/sh\/article\/11\/4\/375\/184919\/Hepatitis-E-in-Australian-HIV-infected-patients-an"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,28]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,9,9]]}},"URL":"https:\/\/doi.org\/10.1071\/sh13198","relation":{},"ISSN":["1448-5028","1449-8987"],"issn-type":[{"value":"1448-5028","type":"print"},{"value":"1449-8987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,28]]}}}